AIHealthcare Analytics

Knowledge Wiki

Wiki › UpDoc — First FDA-Cleared Clinical AI Platform for Real-Time Care Delivery

UpDoc — First FDA-Cleared Clinical AI Platform for Real-Time Care Delivery

ENTITY
Rev 31 Aug 8, 2026 20:31 UTC 4 sources

Overview UpDoc has achieved a landmark regulatory milestone by receiving the first FDA clearance for a Software as a Medical Device (SaMD) incorporating a patient-facing Large Language Model (LLM) in clinical care. This clearance, confirmed across multiple sources in 2026, establishes a new regulatory pathway for clinical AI developers building direct patient-interaction tools. Clearance Significance The UpDoc clearance is notable for two reasons: it is the first FDA-cleared clinical AI platform built for real-time patient care delivery and intelligent care coordination, and it is the first to incorporate a patient-facing LLM within a cleared SaMD framework. McGuireWoods described the clearance as "opening a pathway for clinical AI developers." Medical Design & Outsourcing confirmed UpDoc's self-description as the first FDA-cleared clinical AI platform. Platform Capabilities Per PR Newswire, UpDoc's platform is designed for real-time patient care delivery and care coordination, integrating LLM capabilities within a regulatory-compliant architecture. The 2 Minute Medicine coverage confirmed the patient-facing LLM aspect of the clearance, distinguishing it from prior AI medical device clearances that were primarily clinician-facing or non-generative. Regulatory Context The clearance arrives amid broader debate about FDA's ability to regulate adaptive and generative AI medical devices. A Nature Medicine benchmark study published in June 2026 found that general-purpose LLMs…

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index